FR1452607A - Procédé de fabrication d'anhydrides indolyl-aliphatiques - Google Patents

Procédé de fabrication d'anhydrides indolyl-aliphatiques

Info

Publication number
FR1452607A
FR1452607A FR977783A FR977783A FR1452607A FR 1452607 A FR1452607 A FR 1452607A FR 977783 A FR977783 A FR 977783A FR 977783 A FR977783 A FR 977783A FR 1452607 A FR1452607 A FR 1452607A
Authority
FR
France
Prior art keywords
indolyl
manufacturing process
aliphatic anhydrides
anhydrides
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR977783A
Other languages
English (en)
French (fr)
Inventor
Shen Tsung-Ying
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US296451A external-priority patent/US3201414A/en
Priority claimed from US314503A external-priority patent/US3242185A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of FR1452607A publication Critical patent/FR1452607A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR977783A 1962-01-05 1964-06-10 Procédé de fabrication d'anhydrides indolyl-aliphatiques Expired FR1452607A (fr)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16461562A 1962-01-05 1962-01-05
US28693563 US3161654A (en) 1962-01-05 1963-06-11 alpha-(1-aroyl-3-indolyl) alkanoic acids
US296451A US3201414A (en) 1963-07-22 1963-07-22 New 1-heteroacyl-3-indolyl aliphatic acids
US31045463A 1963-09-20 1963-09-20
US31047763A 1963-09-20 1963-09-20
US314503A US3242185A (en) 1963-10-07 1963-10-07 Lower aliphatic acids, salts and derivatives thereof
US32386363A 1963-11-04 1963-11-04
US321328A US3275644A (en) 1962-01-05 1963-11-04 Certain 1-azolylindol-3-ylaliphatic acids
US321686A US3275645A (en) 1962-01-05 1963-11-06 N-(1-acyl-3-indolyl)-acids
US437338A US3338921A (en) 1962-01-05 1965-01-26 Thenoic and furoic acids
US442152A US3328423A (en) 1962-01-05 1965-03-23 alpha-(3-indolyl)-cyclopropyl lower aliphatic acids
US528020A US3316267A (en) 1962-01-05 1966-02-15 Indolyl acids

Publications (1)

Publication Number Publication Date
FR1452607A true FR1452607A (fr) 1966-04-15

Family

ID=27583773

Family Applications (6)

Application Number Title Priority Date Filing Date
FR977785A Expired FR1426907A (fr) 1962-01-05 1964-06-10 Procédé de fabrication d'acides indolyl-aliphatiques 5-substitués et de leurs dérivés
FR977784A Expired FR1459744A (fr) 1962-01-05 1964-06-10 Procédé de fabrication d'acides 3-indolyl-aliphatiques de leurs dérivés et intermédiaires
FR977783A Expired FR1452607A (fr) 1962-01-05 1964-06-10 Procédé de fabrication d'anhydrides indolyl-aliphatiques
FR987605A Expired FR4114M (en:Method) 1962-01-05 1964-09-09
FR987606A Expired FR4065M (en:Method) 1962-01-05 1964-09-09
FR987607A Expired FR3933M (en:Method) 1962-01-05 1964-09-09

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR977785A Expired FR1426907A (fr) 1962-01-05 1964-06-10 Procédé de fabrication d'acides indolyl-aliphatiques 5-substitués et de leurs dérivés
FR977784A Expired FR1459744A (fr) 1962-01-05 1964-06-10 Procédé de fabrication d'acides 3-indolyl-aliphatiques de leurs dérivés et intermédiaires

Family Applications After (3)

Application Number Title Priority Date Filing Date
FR987605A Expired FR4114M (en:Method) 1962-01-05 1964-09-09
FR987606A Expired FR4065M (en:Method) 1962-01-05 1964-09-09
FR987607A Expired FR3933M (en:Method) 1962-01-05 1964-09-09

Country Status (14)

Country Link
US (6) US3161654A (en:Method)
AT (1) AT290523B (en:Method)
BE (3) BE649167A (en:Method)
BR (4) BR6459897D0 (en:Method)
CH (3) CH447169A (en:Method)
CS (1) CS164201B2 (en:Method)
DE (1) DE1470069A1 (en:Method)
DK (2) DK130922B (en:Method)
FI (1) FI44910C (en:Method)
FR (6) FR1426907A (en:Method)
GB (3) GB1063247A (en:Method)
IL (3) IL21376A (en:Method)
NL (3) NL6406406A (en:Method)
SE (1) SE300985B (en:Method)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242186A (en) * 1960-07-13 1966-03-22 Polaroid Corp 2, 5-dihydroxytriptycyl compounds and processes for their syntheses
US3259622A (en) * 1962-09-07 1966-07-05 Merck & Co Inc 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
US3376316A (en) * 1962-12-28 1968-04-02 Merck & Co Inc Lower alkyl gamma keto acid 2-pyranyl esters
US3306822A (en) * 1963-05-20 1967-02-28 Merck & Co Inc Anti-inflammatory therapy with 3-indolinyl compounds
BE659364A (en:Method) * 1964-02-05
US3450814A (en) * 1964-07-15 1969-06-17 Chemway Corp Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine
US3271394A (en) * 1964-12-31 1966-09-06 Merck & Co Inc Alpha-indolyl-3-acetic acid esters
US3417096A (en) * 1965-07-01 1968-12-17 Bristol Myers Co Certain 5(1-benzoyl-3-indolylmethyl) tetrazoles
US3397211A (en) * 1966-09-09 1968-08-13 Merck & Co Inc Process for preparing 3-indolyl acetic acids
US3471514A (en) * 1966-11-14 1969-10-07 Merck & Co Inc Process for alpha-(5-nitroindolyl-3)-alkanoic acids
US3468907A (en) * 1967-04-10 1969-09-23 Schering Corp Glyceryl esters of alpha-(1-aroyl-3-indolyl)alkanoic acids
BR6898229D0 (pt) * 1967-04-11 1973-04-17 Sumitomo Chemical Co Processo para a producao de derivados do acido 1-cail-3-indolil-alifatico
US3476770A (en) * 1967-04-14 1969-11-04 Parke Davis & Co 2-methyl-7-phenylindole-3-acetic acid compounds
US3501498A (en) * 1967-07-26 1970-03-17 Merck & Co Inc Nitro- and amino-substituted 1-p-chlorobenzyl-2-methyl-3-indolylacetic acids
US3497526A (en) * 1967-07-26 1970-02-24 Merck & Co Inc Organo-metallic compounds
HU162374B (en:Method) * 1969-04-03 1973-02-28
US3800041A (en) * 1971-03-02 1974-03-26 Lilly Co Eli Analgesic compositions and methods
US3939178A (en) * 1971-06-01 1976-02-17 American Home Products Corporation Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
JPS49149723U (en:Method) * 1973-04-25 1974-12-25
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
US4119638A (en) * 1976-11-29 1978-10-10 G. D. Searle & Co. Thio-ester of 1 (p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
DK244179A (da) * 1978-06-13 1979-12-14 Merck & Co Inc Fremgangsmaade til fremstilling af krystallinsk natrium og kaliumindomethacin og trihydrater deraf
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE2943125A1 (de) * 1979-10-25 1981-05-14 Troponwerke GmbH & Co KG, 5000 Köln Verfahren zur herstellung von 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indol acetoxyessigsaeure
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
US4379792A (en) * 1980-10-30 1983-04-12 Merck & Co., Inc. Anti-inflammatory composition
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
LU83138A1 (de) * 1981-02-16 1981-09-11 T Eckert Topische pharmazeutische praeparate,enthaltend salze von alkancarbonsaeuren sowie neue carbonsaeuresalze und verfahren zu ihrer herstellung
DE3206885A1 (de) * 1982-02-26 1983-09-15 Troponwerke GmbH & Co KG, 5000 Köln Indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4407804A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and indomethacin
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
DE3431689A1 (de) * 1984-08-29 1986-03-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 5-acylpyrimidinen
JPS61152656A (ja) * 1984-12-27 1986-07-11 Taiho Yakuhin Kogyo Kk ピペラジン誘導体
EP0418565B1 (en) * 1989-09-21 1994-11-30 American Cyanamid Company Pulsatile once-a-day delivery system for minocycline
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
JPH06501448A (ja) * 1989-12-26 1994-02-17 ノバ　ファーマシューティカル　コーポレイション 無水物プロドラッグ組成物
AU658373B2 (en) * 1990-11-06 1995-04-13 Fgn, Inc. Esters and amides of substituted pyrrole acetic acids
JP2552950B2 (ja) * 1990-11-13 1996-11-13 信越化学工業株式会社 アルコキシシランの製造方法
EP0508586B1 (en) * 1991-03-08 1995-05-31 Fgn, Inc. Substituted indenyl compounds
US5401774A (en) * 1991-03-08 1995-03-28 University Of Arizona Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds
US5143927A (en) * 1991-05-09 1992-09-01 Warner-Lambert Company 3-(thiazolidone, oxazolidinone, imidazolidinone)-indoles as antiinflammatory agents
US5250552A (en) * 1991-05-09 1993-10-05 Warner-Lambert Company 3-[thiazolidinone, oxazolidinone, imidazolidinone]-indoles as antiinflammatory agents
US5124347A (en) * 1991-07-31 1992-06-23 Warner-Lambert Co. 3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents
US5463083A (en) 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5436265A (en) * 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
US5696159A (en) * 1994-08-03 1997-12-09 Cell Pathways, Inc. Lactone compounds for treating patients with precancerous lesions
US5776962A (en) * 1994-08-03 1998-07-07 Cell Pathways, Inc. Lactone compounds for treating patient with precancerous lesions
US5484940A (en) * 1994-11-28 1996-01-16 Grant; Francine S. Substituted 3-indolyl-5-pyrazolone compounds
US5532237A (en) * 1995-02-15 1996-07-02 Merck Frosst Canada, Inc. Indole derivatives with affinity for the cannabinoid receptor
US5639780A (en) * 1995-05-22 1997-06-17 Merck Frosst Canada, Inc. N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
US5604253A (en) * 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
US5874440A (en) * 1995-06-07 1999-02-23 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives
US6060477A (en) * 1995-06-07 2000-05-09 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
US6200980B1 (en) 1995-06-07 2001-03-13 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl purinone derivatives
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
US6262059B1 (en) 1995-06-07 2001-07-17 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with quinazoline derivatives
US6232312B1 (en) 1995-06-07 2001-05-15 Cell Pathways, Inc. Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides
US6046216A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives
US5998477A (en) * 1996-06-13 1999-12-07 Cell Pathways Inc. Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
US6063818A (en) * 1996-06-13 2000-05-16 Cell Pathways Inc. Substituted benzylidene indenyl formamides, acetamides and propionamides
US5965619A (en) * 1996-06-13 1999-10-12 Cell Pathways Inc. Method for treating patients having precancerous lesions with substituted indene derivatives
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
CA2238283C (en) 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US5852035A (en) * 1997-12-12 1998-12-22 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines
US5948779A (en) * 1997-12-12 1999-09-07 Cell Pathways, Inc. Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes
US6046199A (en) * 1998-01-14 2000-04-04 Cell Pathways, Inc. Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives
US6410584B1 (en) * 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US5942520A (en) * 1998-01-27 1999-08-24 Cell Pathways, Inc. Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines
US6028116A (en) * 1998-04-03 2000-02-22 Cell Pathways, Inc. Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
US5990117A (en) * 1998-04-15 1999-11-23 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
US6025394A (en) 1999-01-29 2000-02-15 Cell Pathways, Inc. Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
DE10006139A1 (de) * 2000-02-11 2001-08-16 Merck Patent Gmbh Indol-3-yl-Derivate
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
US6743793B2 (en) * 2000-03-09 2004-06-01 Ono Pharmaceutical Co., Ltd. Indole derivatives, process for preparation of the same and use thereof
AU2001262220A1 (en) * 2000-04-27 2001-11-12 Basilea Pharmaceutica Ag Pyrimidinyl methyl indole derivatives with antibacterial activity
IT1318673B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Farmaci per le disfunzioni sessuali.
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
KR100904599B1 (ko) * 2001-03-08 2009-06-25 아스트라제네카 아베 신규 용도
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
EP1424335A4 (en) * 2001-09-07 2005-11-16 Ono Pharmaceutical Co INDOLE DERIVATIVES
ITMI20020773A1 (it) * 2002-04-11 2003-10-13 Nicox Sa Farmaci per il trattamento dell'artrite
EP1610776A4 (en) * 2003-03-27 2007-03-28 Merck & Co Inc OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
AU2004253159A1 (en) * 2003-06-25 2005-01-06 Vanderbilt University COX-2-targeted imaging agents
JP2007527397A (ja) * 2003-07-01 2007-09-27 マイクロバイア インコーポレイテッド Ｃｏｘ−２及びｆａａｈ阻害剤
ITRM20030394A1 (it) 2003-08-12 2005-02-13 Maria Gabriella Santoro Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
EP1744747A4 (en) * 2004-04-26 2009-12-02 Univ Vanderbilt INDIC ACID AND INDULECTIC ACID DERIVATIVES AS THERAPEUTIC ACTIVITIES WITH REDUCED GASTROINTESTINAL TOXICITY
US7714017B2 (en) * 2004-10-12 2010-05-11 Decode Genetics, Ehf Carboxylic acid peri-substituted bicyclics for occlusive artery disease
JP2008526185A (ja) * 2005-01-04 2008-07-24 ノバルティス アクチエンゲゼルシャフト ヒトｆｐｐｓのｘ線構造およびｆｐｐｓ結合化合物を選択するための使用
CA2635093C (en) * 2006-01-04 2012-06-26 Southern Research Institute Derivatives of sulindac, use thereof and preparation thereof
ES2418153T3 (es) 2006-03-08 2013-08-12 Cortria Corporation Terapia de combinación con inhibidores no selectivos de COX para prevenir lesiones gástricas relacionadas con COX
CN101528222A (zh) 2006-06-19 2009-09-09 范德比尔特大学 用于诊断性和治疗性靶向cox-2的方法和组合物
JP5201660B2 (ja) * 2007-12-27 2013-06-05 独立行政法人産業技術総合研究所 ４−トリフルオロメチルインドール−３−酢酸
CN102924352B (zh) * 2011-08-10 2013-11-20 北京英力科技发展有限公司 一种合成4-巯基苯甲酸酯的方法
EP3078374B1 (en) 2011-10-17 2019-06-19 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
CN102827030B (zh) * 2012-09-24 2014-05-07 复旦大学 一种 (3r, 5r)-3, 5-二羟基-6-氰基己酸酯的制备方法
WO2025085662A1 (en) 2023-10-17 2025-04-24 Vanderbilt University Compounds for tocolytic use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH307633A (de) * 1952-07-23 1955-06-15 Ciba Geigy Verfahren zur Herstellung eines Anthrachinonküpenfarbstoffes.

Also Published As

Publication number Publication date
US3338921A (en) 1967-08-29
FI44910B (en:Method) 1971-11-01
GB1069775A (en) 1967-05-24
CH447169A (de) 1967-11-30
NL6406406A (en:Method) 1964-12-14
NL6406640A (en:Method) 1964-12-14
US3328423A (en) 1967-06-27
IL21454A (en) 1968-05-30
FR3933M (en:Method) 1966-02-21
DK130922C (en:Method) 1975-10-13
BE649167A (en:Method) 1964-12-11
FR4065M (en:Method) 1966-04-04
US3275645A (en) 1966-09-27
US3316267A (en) 1967-04-25
DK130922B (da) 1975-05-05
BR6459899D0 (pt) 1973-09-11
BR6914739D0 (pt) 1973-04-19
CS164201B2 (en:Method) 1975-11-07
CH455775A (de) 1968-05-15
NL6406405A (en:Method) 1964-12-14
BR6459900D0 (pt) 1973-09-11
FR1426907A (fr) 1966-02-04
GB1063247A (en) 1967-03-30
FR4114M (en:Method) 1964-04-25
AT290523B (de) 1971-06-11
BR6459897D0 (pt) 1973-09-11
IL21431A (en) 1968-03-28
CH446333A (de) 1967-11-15
US3161654A (en) 1964-12-15
BE649166A (en:Method) 1964-12-11
SE300985B (en:Method) 1968-05-20
US3275644A (en) 1966-09-27
GB1063230A (en) 1967-03-30
BE649169A (en:Method) 1964-12-11
DE1470069A1 (de) 1969-05-14
FR1459744A (fr) 1966-06-17
FI44910C (fi) 1972-02-10
IL21376A (en) 1968-03-28
DK117068B (da) 1970-03-16

Similar Documents

Publication Publication Date Title
FR1452607A (fr) Procédé de fabrication d'anhydrides indolyl-aliphatiques
FR1368581A (fr) Procédé de transformation de l'acroléine-cyanhydrine
FR1419684A (fr) Procédé perfectionné de fabrication d'epsilon-caprolactames
CH403792A (fr) Procédé de fabrication de l'hydroquinone
BE602539A (fr) Procédé de fabrication d'arylaminopyrazoles
FR1332557A (fr) Procédé de fabrication d'alpha-amino-benzylpénicillines
FR1357894A (fr) Procédé de fabrication d'oxathiazolinones
CH412846A (fr) Procédé de fabrication de l'anhydride acétique
FR1344345A (fr) Procédé de fabrication d'oxiranes
FR1351045A (fr) Procédé de fabrication d'organo-mercuri-hydrazines
FR1377007A (fr) Procédé de fabrication de 1, 8-dihydroxy-anthraquinonyl-5-thioéthers
FR1360191A (fr) Procédé de fabrication d'une alpha-aminobenzylpénicilline
FR1320471A (fr) Procédé de fabrication d'hydroxypénicillines
FR1328598A (fr) Procédé de fabrication d'inhibiteurs-détergents
FR1347169A (fr) Procédé de fabrication d'articulations
FR1292304A (fr) Procédé de fabrication d'alpha épichlorhydrine
FR1320468A (fr) Procédé de fabrication de dihydro-glucosides
FR1321728A (fr) Procédé de fabrication d'anhydride sulfureux
FR1312817A (fr) Procédé de fabrication d'octène-(4)-dione-(2, 7)
FR1379262A (fr) Procédé de fabrication d'organopolysiloxanes
FR1320977A (fr) Procédé de fabrication de l'isoprène
FR1358120A (fr) Procédé de fabrication de fluorochlorobenzènes
FR1306838A (fr) Procédé de fabrication d'oléfines
FR1397542A (fr) Procédé de fabrication d'organothiophosphonates
FR1377712A (fr) Procédé de fabrication d'aryl-tétrachloro-aza-propènes